Based on Globocan 2022, an estimated 180,480 new most cancers circumstances and 120,184 most cancers deaths are anticipated in Vietnam.
Breast most cancers, liver most cancers, and lung most cancers are the commonest cancers in Vietnam, with incidence and mortality charges growing yearly.
This example necessitates the acceleration of most cancers prognosis and remedy high quality enchancment efforts.
On this context, the collaboration program between AstraZeneca Vietnam and Ok Hospital goals to: speed up the hospital’s scientific analysis and worldwide integration; improve the standard of most cancers remedy for sufferers within the northern provinces and throughout the nation; and aspire to make most cancers not a number one reason behind demise in Vietnam.
|
The signing ceremony on June 26 was witnessed by each firms’ leaders and representatives. Photograph courtesy of AstraZeneca Vietnam |
Combining the strengths of a Ok hospital, a central-level hospital, and the main oncology division within the nation with these of AstraZeneca, a number one pharmaceutical firm with medical experience from the U.Ok. and Sweden, the place oncology is a key therapeutic space, the 2 events will deal with key analysis and improvement actions, and strategic collaboration, in conducting medical oncology trials.
They can even set up and develop a community or middle for innovation, digital transformation, analysis, and the appliance of superior applied sciences and synthetic intelligence in healthcare.
As well as, conducting epidemiological and most cancers registry analysis, and collaborating on the institution and implementation of scientific analysis, coaching, and worldwide cooperation packages are additionally talked about within the partnership.
And eventually, the companions will collaborate to advertise complete healthcare coordination packages for most cancers sufferers and assist sufferers in growing entry to superior remedy medication.
In parallel with analysis and improvement actions, AstraZeneca and Ok Hospital can even prioritize selling well being fairness by way of, growing a nationwide most cancers prevention community, and co-implementing the “Love Your Lungs” program to boost consciousness for early detection of lung most cancers locally.
Based on Prof. Dr. Le Van Quang, Director of Ok Hospital, with an built-in and sustainable improvement technique, Ok Hospital’s purpose is to change into a mannequin hospital, main in Vietnam and assembly worldwide requirements in most cancers remedy.
The hospital extremely appreciates the cooperation of AstraZeneca and hopes that sooner or later, the 2 organizations could have extra intensive and in-depth actions within the fields of scientific analysis, medical analysis middle improvement, coaching and worldwide cooperation, group communication, schooling, and assist for most cancers sufferers.
“Collectively, I consider that this cooperation, constructed on a ‘patient-centric’ method, will yield vital and lasting advantages for sufferers and contribute not solely to the development of oncology but in addition to the general improvement of the Vietnamese healthcare sector,” he mentioned.
 |
|
Prof. Dr, Le Van Quang, Director of Ok Hospital, mentioned on the signing ceremony on June 26. Photograph courtesy of AstraZeneca Vietnam |
Constructing on the success of their preliminary collaboration settlement signed in 2019, AstraZeneca and Ok Hospital have additional solidified their strategic partnership by way of this new settlement.
This strengthened collaboration has led to the implementation of quite a few medical trials that adhere to rigorous international requirements.
These trials have yielded vital outcomes, as showcased at main worldwide boards just like the current ASCO 2024 convention within the US.
Moreover, the collaboration has demonstrably enhanced the medical trial capabilities of hospitals and medical professionals.
That is evident of their means to surpass the stringent investigations carried out by giant pharmaceutical firms, medical regulatory our bodies, and respected medical analysis administration organizations (FDA, impartial inspection models, et al).
Atul Tandon, Common Director of AstraZeneca Vietnam, mentioned on the signing ceremony that he was grateful and happy with the achievements each events have made by way of the strategic partnership.
Over time, the unwavering dedication to complete collaboration spanning prognosis, remedy, and holistic look after most cancers sufferers has been repeatedly enhanced and has yielded demonstrably enhanced remedy outcomes in comparison with earlier instances.
Wanting in direction of the long run, he believes that the 2 organizations will proceed to create vital developments in most cancers remedy practices and rework the affected person journey.
“In the end reaching well being fairness for everybody within the nation, fostering a more healthy and extra sustainable future for Vietnam,” the chief mentioned.
 |
|
Atul Tandon, Common Director AstraZeneca Viet Nam. Photograph courtesy of AstraZeneca Vietnam |
Earlier in June, AstraZeneca and Ok Hospital efficiently co-organized the “Nationwide Lung Most cancers Investigator Assembly” to foster data change in lung most cancers analysis between Vietnamese and worldwide consultants.
This collaboration goals to strengthen medical analysis capabilities in hospitals, incomes recognition from the Deputy Minister of Well being for its contribution to Vietnam’s healthcare development.
The convention exemplifies each entities’ dedication to R&D, significantly medical trials, to find new remedies and enhance Vietnam and international most cancers affected person survival charges.
